In contrast, retatrutide, currently undergoing clinical studies, shows promise for enhanced effectiveness, potentially offering up to a 24.2% reduction in mass over 48 weeks
The safety monitoring specifically tracked thyroid outcomes given the known class concerns
Retatrutide is a synthetic drug that simultaneously acts on multiple receptors
Remember, our approach in Temecula involves comprehensive support, from evaluation to prescriptions and insurance handling, ensuring you achieve the health results you desire safely and effectively
Inflammation Reduction GLP 1 medications may help lower certain inflammatory markers in the body
As of mid-2025, retatrutide has not been approved by the MHRA and is not available through NHS prescribing